| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.088 | 0.08 |